Syndax Pharmaceuticals
SNDX
#6582
Rank
โ‚น72.75 B
Marketcap
โ‚น808.08
Share price
-4.49%
Change (1 day)
-45.35%
Change (1 year)

Earnings for Syndax Pharmaceuticals (SNDX)

Earnings in 2026 (TTM): -โ‚น19.53 Billion

According to Syndax Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.28 Billion. In 2025 the company made an earning of -โ‚น26.46 Billion, an increase over its 2024 earnings that were of -โ‚น29.54 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Syndax Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น19.53 Billion-26.19%
2025 -โ‚น26.46 Billion-10.46%
2024 -โ‚น29.54 Billion52.25%
2023 -โ‚น19.41 Billion40.19%
2022 -โ‚น13.84 Billion-699.13%
2021 โ‚น2.30 B-134.07%
2020 -โ‚น6.78 Billion30.53%
2019 -โ‚น5.2 Billion-24.22%
2018 -โ‚น6.86 Billion21.64%
2017 -โ‚น5.64 Billion36.72%
2016 -โ‚น4.13 Billion84.39%
2015 -โ‚น2.24 Billion21.64%
2014 -โ‚น1.84 Billion39.92%
2013 -โ‚น1.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น14.47 Billion-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA